梅斯呼吁:新冠肺炎(COVID-19)应该更名为“新冠病毒感染”

2022-03-18 梅斯医学 梅斯医学

新冠肺炎经历了近3年,已深入到每个角落。但是这种称呼真的合适吗?

新冠肺炎经历了近3年,已深入到每个角落。但是这种称呼真的合适吗?

也许在初期,主要临床表现是大白肺,即肺炎特征比较明显。然而随着奥密克戎的普及,肺炎的征象越来越少,相反,鼻咽的症状是核心症状,那么新冠肺炎是否需要重新命名?

梅斯医学检索了WHO的定义:Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. COVID-19指的是新冠病毒感染者,并不是新冠肺炎!在字面上翻译应该是“2019新冠病毒感染病”

从近期国内和国际的奥密克戎感染来看,奥密克戎在上呼吸系统中的复制速度较快,但在肺部组织中的复制能力较弱。对啮齿动物的研究发现,奥密克戎感染的肺部炎症和损伤较少。从实际临床来看,无症状感染占大多数,另外,轻症也极多。因此,梅斯医学认为,现在将COVID-19再称呼为新冠肺炎,可能有失偏颇。因此,有必要进行正名,统一称呼为“新冠病毒感染”,全称为“新型冠状病毒2感染”,或以WHO的命名“2019新冠病毒病”。

通过更名,至少有以下好处:

1、符合病因命名,源自新冠病毒感染。如果具体症状表现,可以再将其归入上呼吸道感染和下呼吸道感染等。

2、当前奥密克戎感染的特征,肺部的表现相对轻微,再用肺炎命名,并不合适;

3、有助于减少社会对新冠病毒感染的过度紧张,也符合防疫常态化的要求。

因此,梅斯呼吁:新冠肺炎(COVID-19)应该更名为“新冠病毒感染”、全称“新型冠状病毒2感染”、或“2019新冠病毒病”!

参考文献:

1、https://www.who.int/health-topics/coronavirus#tab=tab_1

2、Nature五连发:评估奥密克戎突变株对疫苗和抗体的逃逸

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1277329, encodeId=9fc612e732951, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Mar 20 02:49:50 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497540, encodeId=3fb9149e5404b, content=<a href='/topic/show?id=21146026446' target=_blank style='color:#2F92EE;'>#更名#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60264, encryptionId=21146026446, topicName=更名)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5619335471, createdName=shalley69, createdTime=Sun Mar 20 02:49:50 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203791, encodeId=b47b1203e916f, content=赞同, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Fri Mar 18 14:12:36 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203780, encodeId=c1f91203e801c, content=2019冠状病毒感染病,这应该最合适, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Fri Mar 18 13:53:46 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203762, encodeId=38e11203e627f, content=这个呼吁好, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Fri Mar 18 12:15:19 CST 2022, time=2022-03-18, status=1, ipAttribution=)]
    2022-03-20 一闲
  2. [GetPortalCommentsPageByObjectIdResponse(id=1277329, encodeId=9fc612e732951, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Mar 20 02:49:50 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497540, encodeId=3fb9149e5404b, content=<a href='/topic/show?id=21146026446' target=_blank style='color:#2F92EE;'>#更名#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60264, encryptionId=21146026446, topicName=更名)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5619335471, createdName=shalley69, createdTime=Sun Mar 20 02:49:50 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203791, encodeId=b47b1203e916f, content=赞同, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Fri Mar 18 14:12:36 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203780, encodeId=c1f91203e801c, content=2019冠状病毒感染病,这应该最合适, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Fri Mar 18 13:53:46 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203762, encodeId=38e11203e627f, content=这个呼吁好, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Fri Mar 18 12:15:19 CST 2022, time=2022-03-18, status=1, ipAttribution=)]
    2022-03-20 shalley69
  3. [GetPortalCommentsPageByObjectIdResponse(id=1277329, encodeId=9fc612e732951, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Mar 20 02:49:50 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497540, encodeId=3fb9149e5404b, content=<a href='/topic/show?id=21146026446' target=_blank style='color:#2F92EE;'>#更名#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60264, encryptionId=21146026446, topicName=更名)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5619335471, createdName=shalley69, createdTime=Sun Mar 20 02:49:50 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203791, encodeId=b47b1203e916f, content=赞同, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Fri Mar 18 14:12:36 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203780, encodeId=c1f91203e801c, content=2019冠状病毒感染病,这应该最合适, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Fri Mar 18 13:53:46 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203762, encodeId=38e11203e627f, content=这个呼吁好, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Fri Mar 18 12:15:19 CST 2022, time=2022-03-18, status=1, ipAttribution=)]
    2022-03-18 DR.Fu SIR

    赞同

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1277329, encodeId=9fc612e732951, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Mar 20 02:49:50 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497540, encodeId=3fb9149e5404b, content=<a href='/topic/show?id=21146026446' target=_blank style='color:#2F92EE;'>#更名#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60264, encryptionId=21146026446, topicName=更名)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5619335471, createdName=shalley69, createdTime=Sun Mar 20 02:49:50 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203791, encodeId=b47b1203e916f, content=赞同, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Fri Mar 18 14:12:36 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203780, encodeId=c1f91203e801c, content=2019冠状病毒感染病,这应该最合适, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Fri Mar 18 13:53:46 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203762, encodeId=38e11203e627f, content=这个呼吁好, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Fri Mar 18 12:15:19 CST 2022, time=2022-03-18, status=1, ipAttribution=)]
    2022-03-18 医者仁者

    2019冠状病毒感染病,这应该最合适

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1277329, encodeId=9fc612e732951, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Mar 20 02:49:50 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497540, encodeId=3fb9149e5404b, content=<a href='/topic/show?id=21146026446' target=_blank style='color:#2F92EE;'>#更名#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60264, encryptionId=21146026446, topicName=更名)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5619335471, createdName=shalley69, createdTime=Sun Mar 20 02:49:50 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203791, encodeId=b47b1203e916f, content=赞同, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Fri Mar 18 14:12:36 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203780, encodeId=c1f91203e801c, content=2019冠状病毒感染病,这应该最合适, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Fri Mar 18 13:53:46 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203762, encodeId=38e11203e627f, content=这个呼吁好, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Fri Mar 18 12:15:19 CST 2022, time=2022-03-18, status=1, ipAttribution=)]
    2022-03-18 医者仁者

    这个呼吁好

    0